https://www.selleckchem.com/pr....oducts/tefinostat.ht
Myotonic dystrophy type 2 (DM2) is a rare autosomal dominant multisystemic disease with highly variable clinical presentation. Several case reports and one cohort study suggested a significant association between DM2 and autoimmune diseases (AIDs). The aim of this study is to analyze the frequency and type of AIDs in patients with DM2 from the Serbian DM registry. A total of 131 patients with DM2 from 108 families were included, [62.6% women, mean age at DM2 onset 40.4 (with standard deviation 13) years, age at entering the registry